Neurofolin® was launched in Melbourne, Australia and has been extremely well-received by the public, media and most importantly healthcare professionals.
Coinciding with the launch, research presented at the Australian Society for Bipolar & Depressive Disorders Conference showed that adding Neurofolin® (L-methylfolate 15mg) to standard prescription medications for depression can significantly increase the proportion of patients that respond positively.
Dr Darryl Bassett, a Perth-based psychiatrist and formerly Adjunct Professor of Psychiatry at the University of Notre Dame and Clinical Associate Professor of Psychiatry at the University of Western Australia, says one of the keys to better treatment outcomes in depression is increasing response rates.
"There is certainly a trend globally in depression treatment towards augmenting medications with specialised nutritional support to improve the number of people who benefit. The data from the conference certainly shows how promising that approach is likely to be," said Dr Bassett.
Below are some further links to recent media coverage.
Mammia Colbey had depression for years. Then a little-known supplement pulled him out of the darkness.
If you are a journalist with a media enquiry, please write to us at info@grunbiotics.com and we will respond to your request as soon as possible.
If you are a consumer, healthcare professional, investor, or member of the public please visit the Contact Us page or call Grünbiotics on: +613 8692 0006.